# A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy Volunteers

> **NCT04478513** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 28 (actual)

## Conditions studied

- Healthy Volunteer/DDI Study

## Interventions

- **DRUG:** AZD4635
- **DRUG:** Fluvoxamine

## Key facts

- **NCT ID:** NCT04478513
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-21
- **Primary completion:** 2020-12-23
- **Final completion:** 2020-12-23
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04478513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04478513, "A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04478513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*